BioSpace News Archive

Eledon Pharmaceuticals Receives Health Canada Approval to Commence Human Trials to Evaluate AT-1501 in Kidney Transplantation

Eledon Pharmaceuticals, Inc. received a No Objection Letter (NOL) from Health Canada for its Clinical Trial Application, thereby allowing Eledon to commence a study evaluating AT-1501 as a replacement for tacrolimus as an immunosuppressive regimen component in patients undergoing kidney transplantation.

July 26, 2021
·
4 min read
Business

Poseida Therapeutics Appoints Cynthia Collins to Board of Directors

Poseida Therapeutics, Inc. today announced the appointment of biotechnology industry veteran Cynthia Collins to its Board of Directors, effective July 23, 2021.

July 26, 2021
·
4 min read
Business

INOVIO to Report Second Quarter 2021 Financial Results on August 9, 2021

INOVIO (NASDAQ: INO) announced today that second quarter 2021 financial results will be released after the market close on August 9, 2021.

July 26, 2021
·
4 min read
Lone Star Bio

InGeneron Reports First-In-Human Microscopic Evidence of Adult Tendon Regeneration Following Autologous Stem Cell Treatment

InGeneron, Inc. today announced the publication of the first-in-human comprehensive immunohistochemical evaluation of adult tendon repair following the local injection of fresh, uncultured, unmodified, utologous, adipose derived regenerative cells (UA-ADRCs).

July 26, 2021
·
4 min read
Business

Invacare Corporation to Host Conference Call and Webcast to Discuss Second Quarter 2021 Financial Results

Invacare Corporation announces that it will release its financial results for the second quarter 2021, after the market closes on Wednesday, August 4, 2021.

July 26, 2021
·
2 min read
Genetown

New CDC Guidelines Endorse Opt-Out Screening for Two of the Most Common Sexually Transmitted Infections (STIs), Recommend Nucleic Acid Testing for Mycoplasma Genitalium

Hologic, Inc. (Nasdaq: HOLX) commends the decision by the United States Centers for Disease Control and Prevention (CDC) to endorse an updated approach to screening for Chlamydia trachomatis and Neisseria gonorrhoea, two of the most common sexually transmitted infections (STIs) in the country.

July 26, 2021
·
8 min read
BiomX Inc. Announces $15 Million Registered Direct Offering

The securities are being sold at an offering price of $4.00 per share of the Company’s common stock and an accompanying warrant to purchase 0.75 of a share of the Company’s common stock at an exercise price of $5.00 per share.

July 26, 2021
·
4 min read
Business

Genetic Technologies Rapidly Accelerating Commercialization Plans

Genetic Technologies Limited (NASDAQ: GENE, “Company”, “GTG”), a global leader in Genomics based tests in health, wellness and serious disease, is pleased to provide its Quarterly Business Update to the market.

July 26, 2021
·
8 min read
Business

CORRECTING and REPLACING Fulgent Genetics to Announce Second Quarter 2021 Financial Results on Monday, August 9, 2021

Fulgent Genetics, Inc. - In the headline and first paragraph, first sentence of release, the date should read: Monday, August 9, 2021 (instead of Thursday, August 5, 2021).

July 26, 2021
·
2 min read
Biotech Bay

Cortexyme Presents Data Linking P. Gingivalis to Elevated Levels of Phospho-tau217 Reinforcing Evidence of Pathogen as Causative Agent of Alzheimer’s Disease at AAIC 2021

Cortexyme Presents Data Linking P. Gingivalis to Elevated Levels of Phospho-tau217 Reinforcing Evidence of Pathogen as Causative Agent of Alzheimer’s Disease at AAIC 2021

July 26, 2021
·
11 min read